This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2008 Dec;28(12):2303-4.

doi: 10.1161/ATVBAHA.108.175620. Epub 2008 Sep 18.

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients

Erik S Stroes¹, Melchior C Nierman, Janneke J Meulenberg, Remco Franssen, Jaap Twisk, C Pieter Henny, Mario M Maas, Aeilko H Zwinderman, Colin Ross, Eleonora Aronica, Katherine A High, Marcel M Levi, Michael R Hayden, John J Kastelein, Jan Albert Kuivenhoven

Affiliations

PMID: 18802015
DOI: 10.1161/ATVBAHA.108.175620

Clinical Trial

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients

Erik S Stroes et al. Arterioscler Thromb Vasc Biol. 2008 Dec.

. 2008 Dec;28(12):2303-4.

doi: 10.1161/ATVBAHA.108.175620. Epub 2008 Sep 18.

Authors

Erik S Stroes¹, Melchior C Nierman, Janneke J Meulenberg, Remco Franssen, Jaap Twisk, C Pieter Henny, Mario M Maas, Aeilko H Zwinderman, Colin Ross, Eleonora Aronica, Katherine A High, Marcel M Levi, Michael R Hayden, John J Kastelein, Jan Albert Kuivenhoven

Affiliation

¹ Vascular Medicine, AMC, the Netherlands.

PMID: 18802015
DOI: 10.1161/ATVBAHA.108.175620

No abstract available

PubMed Disclaimer

Similar articles

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Ross CJ, Twisk J, Meulenberg JM, Liu G, van den Oever K, Moraal E, Hermens WT, Rip J, Kastelein JJ, Kuivenhoven JA, Hayden MR. Ross CJ, et al. Hum Gene Ther. 2004 Sep;15(9):906-19. doi: 10.1089/hum.2004.15.906. Hum Gene Ther. 2004. PMID: 15353045
Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.
Ferreira V, Twisk J, Kwikkers K, Aronica E, Brisson D, Methot J, Petry H, Gaudet D. Ferreira V, et al. Hum Gene Ther. 2014 Mar;25(3):180-8. doi: 10.1089/hum.2013.169. Epub 2014 Feb 28. Hum Gene Ther. 2014. PMID: 24299335 Free PMC article. Clinical Trial.
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Rip J, Nierman MC, Sierts JA, Petersen W, Van den Oever K, Van Raalte D, Ross CJ, Hayden MR, Bakker AC, Dijkhuizen P, Hermens WT, Twisk J, Stroes E, Kastelein JJ, Kuivenhoven JA, Meulenberg JM. Rip J, et al. Hum Gene Ther. 2005 Nov;16(11):1276-86. doi: 10.1089/hum.2005.16.1276. Hum Gene Ther. 2005. PMID: 16259561
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.
Gaudet D, de Wal J, Tremblay K, Déry S, van Deventer S, Freidig A, Brisson D, Méthot J. Gaudet D, et al. Atheroscler Suppl. 2010 Jun;11(1):55-60. doi: 10.1016/j.atherosclerosissup.2010.03.004. Epub 2010 Apr 27. Atheroscler Suppl. 2010. PMID: 20427244 Review.
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
Nierman MC, Rip J, Twisk J, Meulenberg JJ, Kastelein JJ, Stroes ES, Kuivenhoven JA. Nierman MC, et al. Neth J Med. 2005 Jan;63(1):14-9. Neth J Med. 2005. PMID: 15719847 Review.

See all similar articles

Cited by

Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.
O'Reilly M, Kohn DB, Bartlett J, Benson J, Brooks PJ, Byrne BJ, Camozzi C, Cornetta K, Crystal RG, Fong Y, Gargiulo L, Gopal-Srivastava R, High KA, Jacobson SG, Jambou RC, Montgomery M, Rosenthal E, Samulski RJ, Skarlatos SI, Sorrentino B, Wilson JM, Xie Y, Corrigan-Curay J. O'Reilly M, et al. Hum Gene Ther. 2013 Apr;24(4):355-62. doi: 10.1089/hum.2013.064. Hum Gene Ther. 2013. PMID: 23517518 Free PMC article.
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis.
Li R, Wang Q, She K, Lu F, Yang Y. Li R, et al. Mol Biomed. 2022 Oct 14;3(1):31. doi: 10.1186/s43556-022-00095-y. Mol Biomed. 2022. PMID: 36239875 Free PMC article. Review.
Molybdenum Cofactor Deficiency in Humans.
Johannes L, Fu CY, Schwarz G. Johannes L, et al. Molecules. 2022 Oct 14;27(20):6896. doi: 10.3390/molecules27206896. Molecules. 2022. PMID: 36296488 Free PMC article. Review.
Gene therapy enters the pharma market: the short story of a long journey.
Büning H. Büning H. EMBO Mol Med. 2013 Jan;5(1):1-3. doi: 10.1002/emmm.201202291. EMBO Mol Med. 2013. PMID: 23283747 Free PMC article. No abstract available.
Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
Welles HC, Jennewein MF, Mason RD, Narpala S, Wang L, Cheng C, Zhang Y, Todd JP, Lifson JD, Balazs AB, Alter G, McDermott AB, Mascola JR, Roederer M. Welles HC, et al. PLoS Pathog. 2018 Dec 5;14(12):e1007395. doi: 10.1371/journal.ppat.1007395. eCollection 2018 Dec. PLoS Pathog. 2018. PMID: 30517201 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information